Pub Date : 2024-11-07DOI: 10.1152/japplphysiol.00657.2024
Diane Salman, Jason Amatoury
The hyoid bone's inferior baseline position in obstructive sleep apnea (OSA) has led to surgical hyoid repositioning (SHR) treatment, yet outcomes vary widely. The influence of baseline hyoid position (BHP; phenotype) and SHR on upper airway (UA) function remains unclear. We aimed to investigate their impact on the UA using computational modeling.
Methods: A validated finite element model of the rabbit UA was advanced and used to simulate changes in BHP and SHR, alone and in combination. The hyoid was displaced in cranial, caudal, anterior, anterior-cranial and anterior-caudal directions from 1-4mm. Model outcomes included UA collapsibility, measured using closing pressure (Pclose), cross-sectional area (CSA) and soft tissue mechanics (displacement, stress and strain).
Results: Graded BHP increments increased Pclose for all directions, and up to 29-43% at 4mm (relative to the original BHP). Anterior-based SHR decreased Pclose (~-115% at 4mm) and increased ΔCSA (~+35% at 4mm). Cranial SHR decreased ΔPclose (-29%), minimally affecting CSA. Caudal SHR increased ΔPclose (+27%) and decreased ΔCSA (-7%). Anterior-cranial and anterior-caudal SHR produced the highest stresses and strains. SHR effects on UA outcomes were dependent on BHP, with more caudal BHPs leading to less effective surgeries.
Conclusion: BHP (phenotype) and SHR both alter UA outcomes, with effects dependent on hyoid displacement direction and magnitude. BHP influences the effectiveness of SHR in reducing UA collapsibility. These findings provide further insights into the hyoid's role in UA patency and suggest that considering the hyoid's baseline position and surgical repositioning direction/increment may help improve hyoid surgeries for OSA treatment.
{"title":"Influence of natural hyoid bone position and surgical repositioning on upper airway patency: A computational finite element modeling study.","authors":"Diane Salman, Jason Amatoury","doi":"10.1152/japplphysiol.00657.2024","DOIUrl":"https://doi.org/10.1152/japplphysiol.00657.2024","url":null,"abstract":"<p><p>The hyoid bone's inferior baseline position in obstructive sleep apnea (OSA) has led to surgical hyoid repositioning (SHR) treatment, yet outcomes vary widely. The influence of baseline hyoid position (BHP; phenotype) and SHR on upper airway (UA) function remains unclear. We aimed to investigate their impact on the UA using computational modeling.</p><p><strong>Methods: </strong>A validated finite element model of the rabbit UA was advanced and used to simulate changes in BHP and SHR, alone and in combination. The hyoid was displaced in cranial, caudal, anterior, anterior-cranial and anterior-caudal directions from 1-4mm. Model outcomes included UA collapsibility, measured using closing pressure (Pclose), cross-sectional area (CSA) and soft tissue mechanics (displacement, stress and strain).</p><p><strong>Results: </strong>Graded BHP increments increased Pclose for all directions, and up to 29-43% at 4mm (relative to the original BHP). Anterior-based SHR decreased Pclose (~-115% at 4mm) and increased ΔCSA (~+35% at 4mm). Cranial SHR decreased ΔPclose (-29%), minimally affecting CSA. Caudal SHR increased ΔPclose (+27%) and decreased ΔCSA (-7%). Anterior-cranial and anterior-caudal SHR produced the highest stresses and strains. SHR effects on UA outcomes were dependent on BHP, with more caudal BHPs leading to less effective surgeries.</p><p><strong>Conclusion: </strong>BHP (phenotype) and SHR both alter UA outcomes, with effects dependent on hyoid displacement direction and magnitude. BHP influences the effectiveness of SHR in reducing UA collapsibility. These findings provide further insights into the hyoid's role in UA patency and suggest that considering the hyoid's baseline position and surgical repositioning direction/increment may help improve hyoid surgeries for OSA treatment.</p>","PeriodicalId":15160,"journal":{"name":"Journal of applied physiology","volume":" ","pages":""},"PeriodicalIF":3.3,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142604662","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-01Epub Date: 2024-10-03DOI: 10.1152/japplphysiol.00559.2024
Seth F McCarthy, Derek P D Bornath, Jessica A L Tucker, Tamara R Cohen, Philip J Medeiros, Tom J Hazell
The potential mechanisms involved in lactate's role in exercise-induced appetite suppression require further examination. We used sodium bicarbonate (NaHCO3) supplementation in a double-blind, placebo-controlled, randomized crossover design to explore lactate's role on neuropeptide Y (NPY), agouti-related peptide (AgRP), and alpha-melanocyte-stimulating hormone (α-MSH) concentrations. Twelve adults (7 males; 24.2 ± 3.4 kg·m-2; 42.18 ± 8.56 mL·kg-1·min-1) completed two identical high-intensity interval training sessions following ingestion of NaHCO3 (BICARB) or sodium chloride (PLACEBO) pre-exercise. Blood lactate, acylated ghrelin, NPY, AgRP, α-MSH, and appetite perceptions were measured pre-exercise, 0-, 30-, 60-, and 90-min postexercise. Free-living energy intake (electronic food diaries) was measured the day before, of, and after each experimental session. In BICARB, blood lactate was greater postexercise (P < 0.002, d > 0.70), though acylated ghrelin was similar (P = 0.075, [Formula: see text] = 0.206) at all time points postexercise (P > 0.034, d < 0.22). NPY (P = 0.006, [Formula: see text] > 0.509) and AgRP (P < 0.001, [Formula: see text] > 0.488) had main effects of time increasing following exercise and returning to baseline, with no differences between sessions (NPY: P = 0.0.192, [Formula: see text] = 0.149; AgRP: P = 0.422, [Formula: see text] = 0.060). α-MSH had no main effect of time (P = 0.573, [Formula: see text] = 0.063) or session (P = 0.269, [Formula: see text] = 0.110). Appetite perceptions were similar during BICARB and PLACEBO (P = 0.007, d = 0.28), increasing in both sessions postexercise (P < 0.088, d > 0.57). Energy intake had a main effect of day (P = 0.025, [Formula: see text] = 0.825), where the experimental session day was greater than the day before (P = 0.010, d = 0.59) with no other differences between days (P > 0.260, d < 0.38). The lower accumulation of lactate than our previous work did not generate exercise-induced appetite suppression as there were no differences in acylated ghrelin, appetite perceptions, or peripheral concentrations of neuropeptides.NEW & NOTEWORTHY Current evidence supports lactate's role in exercise-induced appetite suppression. Here, we demonstrate a smaller degree of lactate accumulation with sodium bicarbonate ingestion and HIIT than our previous work and no subsequent suppression of acylated ghrelin concentrations, subjective appetite perceptions, or peripheral concentrations of neuropeptides. These results suggest either changes in central appetite-regulating neuropeptides are not reflected peripherally or the smaller magnitude of lactate accumulation did not generate exercise-induced appetite suppression as seen previously.
{"title":"Greater lactate accumulation does not alter peripheral concentrations of key appetite-regulating neuropeptides.","authors":"Seth F McCarthy, Derek P D Bornath, Jessica A L Tucker, Tamara R Cohen, Philip J Medeiros, Tom J Hazell","doi":"10.1152/japplphysiol.00559.2024","DOIUrl":"10.1152/japplphysiol.00559.2024","url":null,"abstract":"<p><p>The potential mechanisms involved in lactate's role in exercise-induced appetite suppression require further examination. We used sodium bicarbonate (NaHCO<sub>3</sub>) supplementation in a double-blind, placebo-controlled, randomized crossover design to explore lactate's role on neuropeptide Y (NPY), agouti-related peptide (AgRP), and alpha-melanocyte-stimulating hormone (α-MSH) concentrations. Twelve adults (7 males; 24.2 ± 3.4 kg·m<sup>-2</sup>; 42.18 ± 8.56 mL·kg<sup>-1</sup>·min<sup>-1</sup>) completed two identical high-intensity interval training sessions following ingestion of NaHCO<sub>3</sub> (BICARB) or sodium chloride (PLACEBO) pre-exercise. Blood lactate, acylated ghrelin, NPY, AgRP, α-MSH, and appetite perceptions were measured pre-exercise, 0-, 30-, 60-, and 90-min postexercise. Free-living energy intake (electronic food diaries) was measured the day before, of, and after each experimental session. In BICARB, blood lactate was greater postexercise (<i>P</i> < 0.002, <i>d</i> > 0.70), though acylated ghrelin was similar (<i>P</i> = 0.075, [Formula: see text] = 0.206) at all time points postexercise (<i>P</i> > 0.034, <i>d</i> < 0.22). NPY (<i>P</i> = 0.006, [Formula: see text] > 0.509) and AgRP (<i>P</i> < 0.001, [Formula: see text] > 0.488) had main effects of time increasing following exercise and returning to baseline, with no differences between sessions (NPY: <i>P</i> = 0.0.192, [Formula: see text] = 0.149; AgRP: <i>P</i> = 0.422, [Formula: see text] = 0.060). α-MSH had no main effect of time (<i>P</i> = 0.573, [Formula: see text] = 0.063) or session (<i>P</i> = 0.269, [Formula: see text] = 0.110). Appetite perceptions were similar during BICARB and PLACEBO (<i>P</i> = 0.007, <i>d</i> = 0.28), increasing in both sessions postexercise (<i>P</i> < 0.088, <i>d</i> > 0.57). Energy intake had a main effect of day (<i>P</i> = 0.025, [Formula: see text] = 0.825), where the experimental session day was greater than the day before (<i>P</i> = 0.010, <i>d</i> = 0.59) with no other differences between days (<i>P</i> > 0.260, <i>d</i> < 0.38). The lower accumulation of lactate than our previous work did not generate exercise-induced appetite suppression as there were no differences in acylated ghrelin, appetite perceptions, or peripheral concentrations of neuropeptides.<b>NEW & NOTEWORTHY</b> Current evidence supports lactate's role in exercise-induced appetite suppression. Here, we demonstrate a smaller degree of lactate accumulation with sodium bicarbonate ingestion and HIIT than our previous work and no subsequent suppression of acylated ghrelin concentrations, subjective appetite perceptions, or peripheral concentrations of neuropeptides. These results suggest either changes in central appetite-regulating neuropeptides are not reflected peripherally or the smaller magnitude of lactate accumulation did not generate exercise-induced appetite suppression as seen previously.</p>","PeriodicalId":15160,"journal":{"name":"Journal of applied physiology","volume":" ","pages":"1397-1408"},"PeriodicalIF":3.3,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142365351","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-01Epub Date: 2024-09-19DOI: 10.1152/japplphysiol.00560.2024
Phillip Tracy, Joel Hill, Jai Liester, Kevin Sullivan, James Pearson
Skin heating helps avoid hypothermia in trauma victims but may influence the systolic (SBP) and mean arterial blood pressures (MAP) helping to guide resuscitation. We examined the effect of skin heating on tolerance and arterial blood pressure during lower body negative pressure (LBNP) across four trials. Nine participants completed 15 exercise intervals [60 s 88% peak power output (PPO) and 60 s 10% PPO] in a cold environment (0°C, 70% RH) lowering mean skin temperature (Tsk) before undergoing LBNP to pre syncope where Tsk remained low (Cold Trial: 27.6 ± 1.1°C) or was increased via a water-perfused suit 60 s into LBNP to 32.3 ± 0.7°C (Normothermic Trial), 34.8 ± 0.4°C (Warm Trial), or 36.1 ± 0.8°C (Hot Trial). Tsk was different between trials (P = 0.001). Core temperature was not different between trials, increasing with exercise (36.9 ± 0.3°C to 37.9 ± 0.4°C) and remaining elevated during LBNP (37.7 ± 0.4°C). During LBNP, MAP was greatest in the Cold Trial (88 ± 7 mmHg) and relatively lowered in the Normothermic (83 ± 5 mmHg), Warm (82 ± 5 mmHg), and Hot Trials (79 ± 7 mmHg; all P ≤ 0.017 vs. Cold). SBP was greatest in the Cold (111 ± 9 mmHg) and Normothermic Trials (110 ± 10 mmHg) and relatively lowered in the Warm (105 ± 7 mmHg) and Hot Trials (103 ± 11 mmHg; both P ≤ 0.037). LBNP tolerance was not different between trials (P = 0.746). Following exercise in a cold environment, skin heating during simulated hemorrhage lowers arterial blood pressures and has implications for prehospital care of trauma victims.NEW & NOTEWORTHY Skin heating helps avoid hypothermia in trauma victims but may influence arterial blood pressures, thus helping to guide resuscitation depending on the type of injury. Following exercise in a cold environment, arterial blood pressure was elevated during LBNP with cold skin but lowered with skin heating without changing LBNP tolerance. These findings are important for understanding the effect of skin heating on arterial blood pressure control in the prehospital and combat casualty care of trauma victims.
{"title":"Skin heating during simulated hemorrhage lowers arterial blood pressure but not tolerance following exercise in a cold environment.","authors":"Phillip Tracy, Joel Hill, Jai Liester, Kevin Sullivan, James Pearson","doi":"10.1152/japplphysiol.00560.2024","DOIUrl":"10.1152/japplphysiol.00560.2024","url":null,"abstract":"<p><p>Skin heating helps avoid hypothermia in trauma victims but may influence the systolic (SBP) and mean arterial blood pressures (MAP) helping to guide resuscitation. We examined the effect of skin heating on tolerance and arterial blood pressure during lower body negative pressure (LBNP) across four trials. Nine participants completed 15 exercise intervals [60 s 88% peak power output (PPO) and 60 s 10% PPO] in a cold environment (0°C, 70% RH) lowering mean skin temperature (Tsk) before undergoing LBNP to pre syncope where Tsk remained low (Cold Trial: 27.6 ± 1.1°C) or was increased via a water-perfused suit 60 s into LBNP to 32.3 ± 0.7°C (Normothermic Trial), 34.8 ± 0.4°C (Warm Trial), or 36.1 ± 0.8°C (Hot Trial). Tsk was different between trials (<i>P</i> = 0.001). Core temperature was not different between trials, increasing with exercise (36.9 ± 0.3°C to 37.9 ± 0.4°C) and remaining elevated during LBNP (37.7 ± 0.4°C). During LBNP, MAP was greatest in the Cold Trial (88 ± 7 mmHg) and relatively lowered in the Normothermic (83 ± 5 mmHg), Warm (82 ± 5 mmHg), and Hot Trials (79 ± 7 mmHg; all <i>P</i> ≤ 0.017 vs. Cold). SBP was greatest in the Cold (111 ± 9 mmHg) and Normothermic Trials (110 ± 10 mmHg) and relatively lowered in the Warm (105 ± 7 mmHg) and Hot Trials (103 ± 11 mmHg; both <i>P</i> ≤ 0.037). LBNP tolerance was not different between trials (<i>P</i> = 0.746). Following exercise in a cold environment, skin heating during simulated hemorrhage lowers arterial blood pressures and has implications for prehospital care of trauma victims.<b>NEW & NOTEWORTHY</b> Skin heating helps avoid hypothermia in trauma victims but may influence arterial blood pressures, thus helping to guide resuscitation depending on the type of injury. Following exercise in a cold environment, arterial blood pressure was elevated during LBNP with cold skin but lowered with skin heating without changing LBNP tolerance. These findings are important for understanding the effect of skin heating on arterial blood pressure control in the prehospital and combat casualty care of trauma victims.</p>","PeriodicalId":15160,"journal":{"name":"Journal of applied physiology","volume":" ","pages":"1313-1323"},"PeriodicalIF":3.3,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142287958","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Breakfast skipping has been suggested to be associated with cardiovascular diseases. However, whether breakfast skipping affects vascular endothelial function (VEF), a marker of cardiovascular diseases, remains unclear. This study aimed to investigate the impact of breakfast consumption (Eating trial) and skipping (Skipping trial) on brachial artery (BA) VEF in healthy breakfast eaters. A total of nine healthy individuals (4 females and 5 males) either had breakfast between 830 and 900 or skipped it and had lunch between 1200 and 1230, followed by a 3-h rest period until 1530. For BA VEF evaluation, flow-mediated dilation (FMD) was measured by ultrasound before and after breakfast and lunch. FMD was calculated as the percent change in BA diameter normalized to the shear rate area under the curve (FMD/SRAUC). Blood glucose, plasma insulin, and plasma free fatty acid levels in capillaries were measured before and after breakfast and lunch. At 1530, the Eating trial, but not the Skipping trial, significantly increased FMD/SRAUC from baseline (P = 0.006). The Skipping trial showed significantly lower changes in FMD/SRAUC from 830 than the Eating trial at 1530 (P < 0.001). We found a significant inverse correlation between changes in FMD/SRAUC between 830 and 1530 and peak glucose levels after lunch (r = -0.882, P < 0.001) and with an incremental area under the curve for glucose between 830 and 1530 (r = -0.668, P < 0.001). These results suggest that a single bout of breakfast skipping can suppress BA VEF in the afternoon because of postlunch hyperglycemia.NEW & NOTEWORTHY Skipping breakfast does not affect vascular endothelial function (VEF) before lunch. However, after lunch on normal meals (i.e., not oral glucose tolerance test), VEF was found to be lower in those who skipped breakfast than those who ate breakfast. Such reduced postlunch VEF after skipping breakfast was associated with postprandial hyperglycemia. These results provide important insight into the impact of eating breakfast on VEF and glycemic control in healthy adults.
{"title":"Breakfast skipping suppresses the vascular endothelial function of the brachial artery after lunch.","authors":"Hideaki Kashima, Natsuki Seo, Masako Yamaoka Endo, Masako Kanda, Kohei Miura, Naomi Kashima, Akira Miura, Yoshiyuki Fukuba","doi":"10.1152/japplphysiol.00681.2023","DOIUrl":"10.1152/japplphysiol.00681.2023","url":null,"abstract":"<p><p>Breakfast skipping has been suggested to be associated with cardiovascular diseases. However, whether breakfast skipping affects vascular endothelial function (VEF), a marker of cardiovascular diseases, remains unclear. This study aimed to investigate the impact of breakfast consumption (Eating trial) and skipping (Skipping trial) on brachial artery (BA) VEF in healthy breakfast eaters. A total of nine healthy individuals (4 females and 5 males) either had breakfast between 830 and 900 or skipped it and had lunch between 1200 and 1230, followed by a 3-h rest period until 1530. For BA VEF evaluation, flow-mediated dilation (FMD) was measured by ultrasound before and after breakfast and lunch. FMD was calculated as the percent change in BA diameter normalized to the shear rate area under the curve (FMD/SR<sub>AUC</sub>). Blood glucose, plasma insulin, and plasma free fatty acid levels in capillaries were measured before and after breakfast and lunch. At 1530, the Eating trial, but not the Skipping trial, significantly increased FMD/SR<sub>AUC</sub> from baseline (<i>P</i> = 0.006). The Skipping trial showed significantly lower changes in FMD/SR<sub>AUC</sub> from 830 than the Eating trial at 1530 (<i>P</i> < 0.001). We found a significant inverse correlation between changes in FMD/SR<sub>AUC</sub> between 830 and 1530 and peak glucose levels after lunch (<i>r</i> = -0.882, <i>P</i> < 0.001) and with an incremental area under the curve for glucose between 830 and 1530 (<i>r</i> = -0.668, <i>P</i> < 0.001). These results suggest that a single bout of breakfast skipping can suppress BA VEF in the afternoon because of postlunch hyperglycemia.<b>NEW & NOTEWORTHY</b> Skipping breakfast does not affect vascular endothelial function (VEF) before lunch. However, after lunch on normal meals (i.e., not oral glucose tolerance test), VEF was found to be lower in those who skipped breakfast than those who ate breakfast. Such reduced postlunch VEF after skipping breakfast was associated with postprandial hyperglycemia. These results provide important insight into the impact of eating breakfast on VEF and glycemic control in healthy adults.</p>","PeriodicalId":15160,"journal":{"name":"Journal of applied physiology","volume":" ","pages":"1267-1278"},"PeriodicalIF":3.3,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142287938","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Acute mountain sickness (AMS) represents a considerable issue for individuals sojourning to high altitudes with systemic hypoxemia known to be intimately involved in its development. Based on recent evidence that ketone ester (KE) intake attenuates hypoxemia, we investigated whether exogenous ketosis might mitigate AMS development and identified underlying physiological mechanisms. Fourteen healthy, male participants were enrolled in two 29-h protocols (simulated altitude of 4,000-4,500 m) receiving either KE or a placebo (CON) at regular timepoints throughout the protocol in a randomized, crossover manner. Physiological responses were characterized after 15 min and 4 h in hypoxia, and the protocol was terminated prematurely upon development of severe AMS (Lake Louise Score ≥ 10). KE ingestion induced a consistent diurnal ketosis (d-β-hydroxybutyrate, [βHB] of ∼3 mM), whereas blood [βHB] remained low (<0.6 mM) in CON. Each participant tolerated the protocol equally long or longer (n = 6 or n = 8, respectively) in KE. Protocol duration increased by 32% on average with KE, and doubled upon KE for severe AMS-developing participants (n = 9). Relative to CON, KE induced a mild metabolic acidosis, hyperventilation, and relative sympathetic dominance. KE also inhibited the progressive hypoxemia that was observed between 15 min and 4 h in hypoxia in CON, while concomitantly increasing cerebral oxygenation and capillary Po2 within this timeframe despite a KE-induced reduction in cerebral oxygen supply. These data indicate that exogenous ketosis attenuates AMS development. The key underlying mechanisms include improved arterial and cerebral oxygenation, in combination with lowered cerebral blood flow and oxygen delivery, and increased sympathetic dominance.NEW & NOTEWORTHY Ketone ester intake attenuated the development of acute mountain sickness at a simulated altitude of 4,000-4,500 m. This likely resulted from a mitigation of arterial and cerebral hypoxemia, reduced cerebral blood flow, and increased sympathetic drive.
背景:急性高山反应(AMS)对高海拔地区的人来说是一个相当大的问题,众所周知,全身性低氧血症与急性高山反应的发生密切相关。最近有证据表明,摄入酮酯(KE)可减轻低氧血症,因此我们研究了外源性酮病是否可减轻急性高山反应的发生,并找出其潜在的生理机制:14名健康男性参与者参加了两个为期29小时的方案(模拟海拔4,000-4,500米),以随机、交叉的方式在整个方案的固定时间点摄入KE或安慰剂(CON)。在缺氧 15 分钟和 4 小时后对生理反应进行鉴定,如果出现严重的高山反应(路易斯湖评分≥ 10),则提前终止方案:结果:摄入 KE 可诱导持续的昼夜酮症([ßHB] 约为 3 mM),而血液中的[ßHB]仍然很低(在此时间范围内为 2,尽管 KE 诱导的脑供氧减少):这些数据表明,外源性酮病可减轻 AMS 的发生。其主要机制包括改善动脉和脑氧合,同时降低脑血流量和供氧量,以及增加交感神经支配。
{"title":"Exogenous ketosis attenuates acute mountain sickness and mitigates normobaric high-altitude hypoxemia.","authors":"Myrthe Stalmans, Domen Tominec, Wout Lauriks, Ruben Robberechts, Tadej Debevec, Chiel Poffé","doi":"10.1152/japplphysiol.00190.2024","DOIUrl":"10.1152/japplphysiol.00190.2024","url":null,"abstract":"<p><p>Acute mountain sickness (AMS) represents a considerable issue for individuals sojourning to high altitudes with systemic hypoxemia known to be intimately involved in its development. Based on recent evidence that ketone ester (KE) intake attenuates hypoxemia, we investigated whether exogenous ketosis might mitigate AMS development and identified underlying physiological mechanisms. Fourteen healthy, male participants were enrolled in two 29-h protocols (simulated altitude of 4,000-4,500 m) receiving either KE or a placebo (CON) at regular timepoints throughout the protocol in a randomized, crossover manner. Physiological responses were characterized after 15 min and 4 h in hypoxia, and the protocol was terminated prematurely upon development of severe AMS (Lake Louise Score ≥ 10). KE ingestion induced a consistent diurnal ketosis (d-β-hydroxybutyrate, [βHB] of ∼3 mM), whereas blood [βHB] remained low (<0.6 mM) in CON. Each participant tolerated the protocol equally long or longer (<i>n</i> = 6 or <i>n</i> = 8, respectively) in KE. Protocol duration increased by 32% on average with KE, and doubled upon KE for severe AMS-developing participants (<i>n</i> = 9). Relative to CON, KE induced a mild metabolic acidosis, hyperventilation, and relative sympathetic dominance. KE also inhibited the progressive hypoxemia that was observed between 15 min and 4 h in hypoxia in CON, while concomitantly increasing cerebral oxygenation and capillary Po<sub>2</sub> within this timeframe despite a KE-induced reduction in cerebral oxygen supply. These data indicate that exogenous ketosis attenuates AMS development. The key underlying mechanisms include improved arterial and cerebral oxygenation, in combination with lowered cerebral blood flow and oxygen delivery, and increased sympathetic dominance.<b>NEW & NOTEWORTHY</b> Ketone ester intake attenuated the development of acute mountain sickness at a simulated altitude of 4,000-4,500 m. This likely resulted from a mitigation of arterial and cerebral hypoxemia, reduced cerebral blood flow, and increased sympathetic drive.</p>","PeriodicalId":15160,"journal":{"name":"Journal of applied physiology","volume":" ","pages":"1301-1312"},"PeriodicalIF":3.3,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142347217","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-01Epub Date: 2024-09-05DOI: 10.1152/japplphysiol.00469.2024
Tomas Urianstad, Simone Villanova, Ingvill Odden, Joar Hansen, Knut S Mølmen, Simone Porcelli, Bent R Rønnestad, Daniele A Cardinale
Altitude training is a cornerstone for endurance athletes for improving blood variables and performance, with optimal effects observed at ∼2,300-2,500 meters above sea level (m.a.s.l.). However, elite cyclists face challenges such as limited access to such altitudes, inadequate training facilities, and high expenses. To address these issues, a novel method involving daily exposure to carbon monoxide (CO) has been proposed to amplify altitude training adaptations at suboptimal altitudes. Thirty-one male cyclists were assigned to three groups: Live-High Train-High with CO inhalation (LHTHCO), Live-High Train-High (LHTH), and Live-Low Train-Low (LLTL). The LHTHCO group underwent CO inhalation twice daily in the afternoon/evening to elevate carboxyhemoglobin concentration to ∼10%. Hematological variables, in vivo muscle oxidative capacity, and physiological indicators of cycling performance were assessed before and after a 3-week altitude training camp at 2,100 m.a.s.l. LHTHCO demonstrated a larger increase in hemoglobin mass (Hbmass) compared to both LHTH and LLTL. Although there were no statistical differences between LHTHCO and LHTH in submaximal and maximal performance measures, LHTHCO displayed greater improvements in 1-min maximal power output during incremental testing (Wmax), power output at lactate threshold, and maximal oxygen consumption (V̇o2max) compared to LLTL. LHTH demonstrated a larger improvement than LLTL in Wmax and V̇o2max, with no group differences in Hbmass or submaximal measures. Muscle oxidative capacity did not differ between groups. These findings suggest that combining moderate-altitude training with daily CO inhalation promotes hematological adaptations more effectively than moderate altitude alone and enhances cycling performance metrics in cyclists more than sea-level training.NEW & NOTEWORTHY Three weeks of training at moderate altitude with exposure to low doses of CO can significantly enhance hematological adaptations in elite cyclists compared to moderate-altitude training alone. Cycling performance determinants improved more with CO inhalation at moderate altitude compared to sea-level training, whereas there were no differences in submaximal and maximal performance measures compared to moderate-altitude training alone. This study highlights the potential of CO supplementation as an effective adjunct to altitude training regimens.
{"title":"Carbon monoxide supplementation: evaluating its potential to enhance altitude training effects and cycling performance in elite athletes.","authors":"Tomas Urianstad, Simone Villanova, Ingvill Odden, Joar Hansen, Knut S Mølmen, Simone Porcelli, Bent R Rønnestad, Daniele A Cardinale","doi":"10.1152/japplphysiol.00469.2024","DOIUrl":"10.1152/japplphysiol.00469.2024","url":null,"abstract":"<p><p>Altitude training is a cornerstone for endurance athletes for improving blood variables and performance, with optimal effects observed at ∼2,300-2,500 meters above sea level (m.a.s.l.). However, elite cyclists face challenges such as limited access to such altitudes, inadequate training facilities, and high expenses. To address these issues, a novel method involving daily exposure to carbon monoxide (CO) has been proposed to amplify altitude training adaptations at suboptimal altitudes. Thirty-one male cyclists were assigned to three groups: Live-High Train-High with CO inhalation (LHTH<sub>CO</sub>), Live-High Train-High (LHTH), and Live-Low Train-Low (LLTL). The LHTH<sub>CO</sub> group underwent CO inhalation twice daily in the afternoon/evening to elevate carboxyhemoglobin concentration to ∼10%. Hematological variables, in vivo muscle oxidative capacity, and physiological indicators of cycling performance were assessed before and after a 3-week altitude training camp at 2,100 m.a.s.l. LHTH<sub>CO</sub> demonstrated a larger increase in hemoglobin mass (Hb<sub>mass</sub>) compared to both LHTH and LLTL. Although there were no statistical differences between LHTH<sub>CO</sub> and LHTH in submaximal and maximal performance measures, LHTH<sub>CO</sub> displayed greater improvements in 1-min maximal power output during incremental testing (W<sub>max</sub>), power output at lactate threshold, and maximal oxygen consumption (V̇o<sub>2max</sub>) compared to LLTL. LHTH demonstrated a larger improvement than LLTL in W<sub>max</sub> and V̇o<sub>2max</sub>, with no group differences in Hb<sub>mass</sub> or submaximal measures. Muscle oxidative capacity did not differ between groups. These findings suggest that combining moderate-altitude training with daily CO inhalation promotes hematological adaptations more effectively than moderate altitude alone and enhances cycling performance metrics in cyclists more than sea-level training.<b>NEW & NOTEWORTHY</b> Three weeks of training at moderate altitude with exposure to low doses of CO can significantly enhance hematological adaptations in elite cyclists compared to moderate-altitude training alone. Cycling performance determinants improved more with CO inhalation at moderate altitude compared to sea-level training, whereas there were no differences in submaximal and maximal performance measures compared to moderate-altitude training alone. This study highlights the potential of CO supplementation as an effective adjunct to altitude training regimens.</p>","PeriodicalId":15160,"journal":{"name":"Journal of applied physiology","volume":" ","pages":"1092-1105"},"PeriodicalIF":3.3,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142140196","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-01Epub Date: 2024-10-17DOI: 10.1152/japplphysiol.00629.2024
Natalie J Nokoff, Travis Nemkov, Samantha Bothwell, Melanie G Cree, Kelly N Z Fuller, Amy C Keller, Megan M Kelsey, Kristen J Nadeau, Kerrie L Moreau
There are known sex differences in cardiorespiratory fitness (CRF). Little is known about the impact of pubertal blockade with a gonadotropin-releasing hormone agonist (GnRHa) followed by hormone therapy on CRF for transgender adolescents. We aimed to 1) determine the effect of GnRHa monotherapy on CRF and mitochondrial function and associations with metabolomic profiles and 2) evaluate changes after 1 and 12 mo of testosterone therapy among transgender adolescents. Participants assigned female at birth (n = 19, baseline age of 15.0 ± 1.0 yr) from two groups: GnRHa+ (n = 8) and GnRHa- (n = 11) were examined at baseline and 1- and 12-mo post-testosterone therapy in a longitudinal observational study to assess cardiorespiratory fitness, mitochondrial respiration, and metabolic profile. Fasted morning labs included assessment of metabolomics and peripheral blood mononuclear cell mitochondrial respiration and degree of mitochondrial coupling (respiratory control ratio, RCR). A graded cycle ergometer test was performed. Baseline differences were evaluated between groups. Changes were compared with mixed linear regression models evaluating time (baseline, 1 mo, and 12 mo), group (GnRHa treatment yes/no), and their interaction. At baseline GnRHa+ individuals had higher relative V̇o2peak (30.1 ± 4.83 vs. 25.24 ± 4.47 mL/kg/min, P = 0.042) than GnRHa- individuals. In regression models, GnRHa+ individuals had a significant increase in peak watts (P = 0.011) and total exercise time (P = 0.005) after 12 mo of testosterone (P = 0.012) but not GnRHa- individuals. GnRHa+ individuals have significantly higher RCR under carbohydrate (P = 0.0007) and lipid (P = 0.0002) conditions than GnRHa+ individuals. Pretreatment with GnRHa positively influences peak CRF and mitochondrial respiration in adolescent transgender males undergoing testosterone therapy.NEW & NOTEWORTHY This study demonstrates differences in exercise capacity and mitochondrial respiration at baseline based on whether or not individuals had feminizing puberty blocked. Individuals who had puberty blocked had greater improvements in cardiopulmonary exercise testing parameters after 12 mo of testosterone than those who went through feminizing puberty.
{"title":"Differences in cardiorespiratory fitness by gonadotropin-releasing hormone agonist treatment before and after testosterone in transgender adolescents.","authors":"Natalie J Nokoff, Travis Nemkov, Samantha Bothwell, Melanie G Cree, Kelly N Z Fuller, Amy C Keller, Megan M Kelsey, Kristen J Nadeau, Kerrie L Moreau","doi":"10.1152/japplphysiol.00629.2024","DOIUrl":"10.1152/japplphysiol.00629.2024","url":null,"abstract":"<p><p>There are known sex differences in cardiorespiratory fitness (CRF). Little is known about the impact of pubertal blockade with a gonadotropin-releasing hormone agonist (GnRHa) followed by hormone therapy on CRF for transgender adolescents. We aimed to <i>1</i>) determine the effect of GnRHa monotherapy on CRF and mitochondrial function and associations with metabolomic profiles and <i>2</i>) evaluate changes after 1 and 12 mo of testosterone therapy among transgender adolescents. Participants assigned female at birth (<i>n</i> = 19, baseline age of 15.0 ± 1.0 yr) from two groups: GnRHa<sup>+</sup> (<i>n</i> = 8) and GnRHa<sup>-</sup> (<i>n</i> = 11) were examined at baseline and 1- and 12-mo post-testosterone therapy in a longitudinal observational study to assess cardiorespiratory fitness, mitochondrial respiration, and metabolic profile. Fasted morning labs included assessment of metabolomics and peripheral blood mononuclear cell mitochondrial respiration and degree of mitochondrial coupling (respiratory control ratio, RCR). A graded cycle ergometer test was performed. Baseline differences were evaluated between groups. Changes were compared with mixed linear regression models evaluating time (baseline, 1 mo, and 12 mo), group (GnRHa treatment yes/no), and their interaction. At baseline GnRHa<sup>+</sup> individuals had higher relative V̇o<sub>2peak</sub> (30.1 ± 4.83 vs. 25.24 ± 4.47 mL/kg/min, <i>P</i> = 0.042) than GnRHa<sup>-</sup> individuals. In regression models, GnRHa<sup>+</sup> individuals had a significant increase in peak watts (<i>P</i> = 0.011) and total exercise time (<i>P</i> = 0.005) after 12 mo of testosterone (<i>P</i> = 0.012) but not GnRHa<sup>-</sup> individuals. GnRHa<sup>+</sup> individuals have significantly higher RCR under carbohydrate (<i>P</i> = 0.0007) and lipid (<i>P</i> = 0.0002) conditions than GnRHa<sup>+</sup> individuals. Pretreatment with GnRHa positively influences peak CRF and mitochondrial respiration in adolescent transgender males undergoing testosterone therapy.<b>NEW & NOTEWORTHY</b> This study demonstrates differences in exercise capacity and mitochondrial respiration at baseline based on whether or not individuals had feminizing puberty blocked. Individuals who had puberty blocked had greater improvements in cardiopulmonary exercise testing parameters after 12 mo of testosterone than those who went through feminizing puberty.</p>","PeriodicalId":15160,"journal":{"name":"Journal of applied physiology","volume":" ","pages":"1470-1483"},"PeriodicalIF":3.3,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11573275/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142466232","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-01Epub Date: 2024-09-05DOI: 10.1152/japplphysiol.00091.2024
Frederic J F Viseux, Maxime Billot, Grant Handrigan, Martin Simoneau
We explored whether ankle torque variability or plantar perceptual threshold explains human balance control more effectively. We hypothesized that ankle torque variance is a better indicator of center of pressure (COP) velocity variance than plantar perceptual sensitivity. Two conditions were tested: loaded (23-kg vest added) and unloaded, as loading should diminish plantar sensitivity and increase COP velocity variability. We created a linear feedback model to assess the noise change in the sensorimotor loop induced by loading. Plantar sensitivity was quantified using a psychophysical approach while participants stood barefoot. A linear motor applied a force impulse on the participant's heel. A "yes-no" method of limits was selected to identify plantar sole sensory thresholds in both conditions. We observed reduced plantar sensitivity in loaded compared with unloaded conditions. In the loaded condition, participants exhibited greater COP velocity variance, with significant positive Pearson's correlations confirming a substantial association between ankle torque and COP velocity variances for both loaded [variance accounted for (VAF): r2 = 44.56%, P = 0.018] and unloaded conditions (VAF: r2 = 58.83%, P = 0.004). No significant correlation existed between COP velocity variance and plantar sensitivity threshold for both loaded (VAF: r2 = 0.002%, P = 0.99) and unloaded conditions (VAF: r2 = 21.81%, P = 0.35). The model confirmed an ∼88% rise in sensorimotor loop noise in the loaded condition. Ankle torque variance assesses the precision of nonperceptual and perceptual detection mechanisms in evaluating whole body motions and the accuracy in converting sensory cues into ankle torque.NEW & NOTEWORTHY Plantar cutaneous information contributes to balance control by modulating motor commands, but plantar perceptual sensitivity is a suboptimal indicator of balance performance. Multiple sensory cues encode whole body dynamics, guiding sensorimotor mechanisms to minimize body sway variability. Ankle torque variance is proposed as a superior measure for explaining balance control performance and evaluating the sensorimotor loop's functioning in balance control.
{"title":"Ankle torque variance is a better indicator of balance control performance than plantar perceptual sensitivity threshold.","authors":"Frederic J F Viseux, Maxime Billot, Grant Handrigan, Martin Simoneau","doi":"10.1152/japplphysiol.00091.2024","DOIUrl":"10.1152/japplphysiol.00091.2024","url":null,"abstract":"<p><p>We explored whether ankle torque variability or plantar perceptual threshold explains human balance control more effectively. We hypothesized that ankle torque variance is a better indicator of center of pressure (COP) velocity variance than plantar perceptual sensitivity. Two conditions were tested: loaded (23-kg vest added) and unloaded, as loading should diminish plantar sensitivity and increase COP velocity variability. We created a linear feedback model to assess the noise change in the sensorimotor loop induced by loading. Plantar sensitivity was quantified using a psychophysical approach while participants stood barefoot. A linear motor applied a force impulse on the participant's heel. A \"yes-no\" method of limits was selected to identify plantar sole sensory thresholds in both conditions. We observed reduced plantar sensitivity in loaded compared with unloaded conditions. In the loaded condition, participants exhibited greater COP velocity variance, with significant positive Pearson's correlations confirming a substantial association between ankle torque and COP velocity variances for both loaded [variance accounted for (VAF): <i>r</i><sup>2</sup> = 44.56%, <i>P</i> = 0.018] and unloaded conditions (VAF: <i>r</i><sup>2</sup> = 58.83%, <i>P</i> = 0.004). No significant correlation existed between COP velocity variance and plantar sensitivity threshold for both loaded (VAF: <i>r</i><sup>2</sup> = 0.002%, <i>P</i> = 0.99) and unloaded conditions (VAF: <i>r</i><sup>2</sup> = 21.81%, <i>P</i> = 0.35). The model confirmed an ∼88% rise in sensorimotor loop noise in the loaded condition. Ankle torque variance assesses the precision of nonperceptual and perceptual detection mechanisms in evaluating whole body motions and the accuracy in converting sensory cues into ankle torque.<b>NEW & NOTEWORTHY</b> Plantar cutaneous information contributes to balance control by modulating motor commands, but plantar perceptual sensitivity is a suboptimal indicator of balance performance. Multiple sensory cues encode whole body dynamics, guiding sensorimotor mechanisms to minimize body sway variability. Ankle torque variance is proposed as a superior measure for explaining balance control performance and evaluating the sensorimotor loop's functioning in balance control.</p>","PeriodicalId":15160,"journal":{"name":"Journal of applied physiology","volume":" ","pages":"1082-1091"},"PeriodicalIF":3.3,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142140195","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-01Epub Date: 2024-09-26DOI: 10.1152/japplphysiol.00658.2024
Yasmine Coovadia, Charlotte W Usselman
{"title":"Implementing the cold pressor test in cardiovascular research: Does limb choice matter?","authors":"Yasmine Coovadia, Charlotte W Usselman","doi":"10.1152/japplphysiol.00658.2024","DOIUrl":"10.1152/japplphysiol.00658.2024","url":null,"abstract":"","PeriodicalId":15160,"journal":{"name":"Journal of applied physiology","volume":" ","pages":"1194-1195"},"PeriodicalIF":3.3,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142347218","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-01Epub Date: 2024-10-03DOI: 10.1152/japplphysiol.00394.2024
Freek Van de Casteele, Ruud Van Thienen, Oscar Horwath, William Apró, Thibaux Van der Stede, Marcus Moberg, Eline Lievens, Wim Derave
Human skeletal muscle fiber type composition varies greatly along the muscle, so one biopsy may not accurately represent the whole muscle. Recommendations on the number of biopsies and fiber counts using immunohistochemistry and whether these findings can be extrapolated to other muscles are lacking. We assessed fiber type composition in the vastus lateralis and gastrocnemius medialis muscles of 40 individuals. Per muscle, we took four biopsy samples from one incision, collecting two samples each from a proximally and distally directed needle. Based on another dataset involving 10 vastus lateralis biopsies per participant (n = 7), we calculated 95% limits of agreement for subsets of biopsies and fiber counts compared with the 10-biopsy average. Average absolute differences in type I fiber proportions between proximal and distal, and between within-needle samples were 6.9 and 4.5 percentage points in the vastus lateralis, and 5.5 and 4.4 percentage points in the gastrocnemius medialis, respectively. The 95% limits of agreement narrowed to ±10 percentage points when 200 fibers from at least three biopsies were analyzed, with minimal improvements with greater fiber counts. Type I fiber proportions in the vastus lateralis and gastrocnemius medialis showed a moderate positive association (r2 = 0.22; P = 0.006; at least 200 fibers in each of three to four samples per muscle). In conclusion, three biopsies with a minimum of 200 counted fibers are required to estimate the vastus lateralis fiber type composition within ±10 percentage points. Even when using these standards, researchers should be cautious when extrapolating muscle fiber type proportions from one muscle to another.NEW & NOTEWORTHY Fiber type composition is equally variable in muscle biopsy samples taken from one incision as from multiple incisions. Hence, we propose two biopsies from a single incision-needles directed proximally and distally, and each rotated 180° for cutting a second sample-as a more feasible, less invasive alternative to three biopsies from as many incisions. In addition, we identified the gastrocnemius medialis as a slow-twitch muscle with an average of 64.7% slow fibers.
{"title":"Does one biopsy cut it? Revisiting human muscle fiber type composition variability using repeated biopsies in the vastus lateralis and gastrocnemius medialis.","authors":"Freek Van de Casteele, Ruud Van Thienen, Oscar Horwath, William Apró, Thibaux Van der Stede, Marcus Moberg, Eline Lievens, Wim Derave","doi":"10.1152/japplphysiol.00394.2024","DOIUrl":"10.1152/japplphysiol.00394.2024","url":null,"abstract":"<p><p>Human skeletal muscle fiber type composition varies greatly along the muscle, so one biopsy may not accurately represent the whole muscle. Recommendations on the number of biopsies and fiber counts using immunohistochemistry and whether these findings can be extrapolated to other muscles are lacking. We assessed fiber type composition in the vastus lateralis and gastrocnemius medialis muscles of 40 individuals. Per muscle, we took four biopsy samples from one incision, collecting two samples each from a proximally and distally directed needle. Based on another dataset involving 10 vastus lateralis biopsies per participant (<i>n</i> = 7), we calculated 95% limits of agreement for subsets of biopsies and fiber counts compared with the 10-biopsy average. Average absolute differences in type I fiber proportions between proximal and distal, and between within-needle samples were 6.9 and 4.5 percentage points in the vastus lateralis, and 5.5 and 4.4 percentage points in the gastrocnemius medialis, respectively. The 95% limits of agreement narrowed to ±10 percentage points when 200 fibers from at least three biopsies were analyzed, with minimal improvements with greater fiber counts. Type I fiber proportions in the vastus lateralis and gastrocnemius medialis showed a moderate positive association (<i>r</i><sup>2</sup> = 0.22; <i>P</i> = 0.006; at least 200 fibers in each of three to four samples per muscle). In conclusion, three biopsies with a minimum of 200 counted fibers are required to estimate the vastus lateralis fiber type composition within ±10 percentage points. Even when using these standards, researchers should be cautious when extrapolating muscle fiber type proportions from one muscle to another.<b>NEW & NOTEWORTHY</b> Fiber type composition is equally variable in muscle biopsy samples taken from one incision as from multiple incisions. Hence, we propose two biopsies from a single incision-needles directed proximally and distally, and each rotated 180° for cutting a second sample-as a more feasible, less invasive alternative to three biopsies from as many incisions. In addition, we identified the gastrocnemius medialis as a slow-twitch muscle with an average of 64.7% slow fibers.</p>","PeriodicalId":15160,"journal":{"name":"Journal of applied physiology","volume":" ","pages":"1341-1353"},"PeriodicalIF":3.3,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142365349","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}